CROI 2016: HIV-Related Factors Increase Risk of Stroke

alt

HIV-related risk factors seem to increase the risk of stroke -- the sudden death of brain cells due to a rupture or obstruction of blood vessels in the brain -- according to ongoing research in a growing number of large epidemiological cohort studies. Recent data from 5 of these were presented during the first-ever poster discussion session on stroke at the Conference on Retroviruses and Opportunistic Infections (CROI), which took place last month in Boston.

Among the key findings:

Stroke in People with HIV

Stroke is a relatively neglected aspect of HIV-related disease, according to Richard Price from the University of California at San Francisco, who moderated the poster discussion session. He believes this may be partly because strokes are relatively uncommon, and because it tends to get addressed as part of the broader aspect of cardiovascular disease in people with HIV. Another reason may be that stroke is underemphasized, underreported, or misreported because of challenges in characterizing it and confirming a diagnosis.

But given the consequences of stroke -- which can include permanent paralysis, loss of speech, and death -- it is important to determine whether there are aspects of HIV-associated stroke that are distinct from non-HIV-related stroke and from other HIV-related cardiovascular disease.

Risk Factors for Stroke with a More Certain Diagnosis

Much of the earlier research on stroke in people with HIV came from small single-site studies that used diagnostic criteria which may not have caught all the strokes accurately and which did not provide much information about the types of stroke.

So the first study presented in the session attempted to ascertain what are the risk factors for different types of stroke in a very large HIV cohort study, the Center for AIDS Research Network of Integrated Clinical Systems (CNICS). The analysis included 17,000 HIV-positive people who experienced 212 strokes over the course of the study.

The researchers used more sensitive diagnostic criteria to detect and classify the types and subtypes of stroke, with each diagnosis confirmed by 2 neurologists (or 2 out of 3 when there were discrepancies). They also determined whether a stroke occurred in the setting of an acute infection (such as toxoplasmosis) or illicit drug use.

Most of the strokes (81%) were ischemic, 10% were hemorrhagic, and the remainder could not be classified. Among the ischemic strokes, 30% were small vessel, 28% were cardioembolic, 19% were atheroembolic, and 23% were other types or unknown.

Risk factors strongly associated with stroke included smoking (adjusted hazard ratio [aHR] 2.23) and diabetes (aHR 2.74). In addition to traditional cardiovascular risk factors such as age and sex, HIV factors were also significantly associated with these outcomes, such as time-updated viral load (aHR 1.08 for each log higher) and time-updated CD4 cell count (aHR 0.88 for each 100 cells/mm3 lower).

Approximately a fifth of the strokes occurred among people who had an acute infection of some sort, and approximately a fifth occurred in the setting of substance use.

"Strokes were predominantly ischemic and associated not only with traditional risk factors but with lower CD4 count and higher viral load suggesting we have one more reason to be initiating ART a little earlier rather than later," said Heidi Crane from the University of Washington in Seattle, who presented the study.

Predictors of Ischemic and Hemorrhagic Strokes

Another study investigated whether there were differences in risk factors for hemorrhagic and ischemic strokes in the more than 43,000 HIV-positive participants in the D:A:D(Data Collection on Adverse Events of Anti-HIV Drugs) cohort between 1999 and 2014. The study used separate univariable and multivariable regression models to identify associations between demographic, cardiovascular, and HIV-related risk factors for both types of stroke.

There were 83 hemorrhagic and 296 ischemic stroke events during the study period. Risk factors included older age, male sex, smoking, elevated blood pressure, previous cardiovascular disease, diabetes, dyslipidemia(abnormal blood fat levels), a body mass index below 18, injection drug use, and a previous AIDS diagnosis.

The greater risk for hemorrhagic stroke associated with elevated blood pressure and low CD4 cell count was not seen when formally tested in another model. However, this may have been due to a limited number of hemorrhagic strokes. Analyses on competing risks are still ongoing according to presenter Camilla Hatleberg from the University of Copenhagen in Denmark.

"Our findings are mostly similar to those reported in the general population, and emphasize the need for preventive measures in screening," she said. "Further research is needed into the use of stratified stroke risk factors to provide more precise risk estimation."

HIV-Related Factors Increase Stroke Risk in Women

Felicia Chow from the University of California at San Francisco previously presented data from the PARTNERS cohort, which includes over 4000 HIV-positive individuals and over 30,000 HIV-negative control subjects, showing that HIV is an independent risk factor for ischemic stroke (hazard ratio 1.21). The researchers then looked more closely at the data.

"We stratified by sex, and after doing that we found that a lot of the increased stroke risk in this cohort was actually driven by women," Chow said.

She and her colleagues performed another study of 1200 women with HIV and over 12,000 control women to see whether the increased ischemic stroke risk among HIV-positive women persisted after adjustment for demographics, ischemic stroke risk factors, and sex-specific stroke risk factors including menopause status, estrogen use, pregnancy, history of eclampsia, hysterectomy, migraines, and depression.

Before adjustment for other factors, the hazard ratio for HIV being associated with ischemic stroke was 2.43. After adjustment for age, race, vascular, and sex-specific risk factors, HIV infection was still associated with nearly twice the risk of ischemic stroke (hazard ratio 1.88).

Treating HIV earlier might help mitigate the risk, however. In an HIV-only model adjusted for age and race, each additional year of ART use was associated with a 13% lower risk of ischemic stroke.

HCV-Related Risk Factors

The protective effect of ART was confirmed by a study in Spain that ran from 1997 to 2011. Researchers used the Spanish Minimum Basic Data Set -- a clinical and administrative database with information obtained at hospital discharge, with an estimated coverage of around 98% of admissions at nearly 300 public hospitals. Data on more than 3400 individuals with HIV, including close to 1000 HIV/HCV co-infected people living in Spain during the study period, were obtained from the National Centre of Epidemiology.

The incidence of stroke among these hospitalized HIV-positive patients was quite high, but among people with HIV alone it fell progressively over the course of the study, from 16.0 events per 10,000 person-years in the years between 1997-1999 down to 9.2 events during 2000-2003 and 5.5 events during 2004-2011. Strokes have increased, however, among people who are both HIV- and HCV-positive.

During the discussion, other presenters noted that they had not observed a growing risk among HIV/HCV coinfected people, but said that it was difficult to tease this out from the increased risk associated with drug use.

Juan Berenguer from Hospital General Universitario Gregorio Marañón in Madrid, who presented the data, agreed.

"Many studies -- not only this -- have identified HCV coinfection as a risk factor," he said. "The problem is, what is due to biology, to the HCV, and what is due to lifestyle? I think it is very difficult to tease apart the contribution, but probably lifestyle [matters] a lot -- including drug use and the complications of drug use."

Carotid Plaque and Cerebrovascular Events

 

Carotid plaque, a build-up of cholesterol and other debris in the carotid arteries on each side of the neck, occurs often in people living with HIV and isassociated with worse clinical outcomes. The final study presented during the stroke session, by Sumbal Janjua of Massachusetts General Hospital in Boston, found that carotid plaque is common in individuals with HIV even prior to cardiovascular disease and was associated with an increased risk of subsequent cerebrovascular events.

This was a retrospective multi-site study of people with neck CAT scans with contrast (which can reveal carotid plaque) from 6 partner institutions between 2005 and 2014. The analysis excluded anyone with prior cardiovascular or cerebrovascular disease, as well as anyone who had incomplete scans.

The study included 182 people with HIV and 159 HIV-negative control subjects matched for age, sex, diabetes, hypertension, hyperlipidemia, and baseline medications. The prevalence of any carotid plaque was significantly higher in the HIV cohort as compared to the matched controls. Also, the prevalence of non-calcified plaque and other plaque features deemed to pose a high risk of cerebrovascular events -- including spotty calcification scores and low attenuation-- was higher in the HIV cohort as compared to the matched controls.

Discussion

Plaques, particularly in the carotid arteries, may significantly increase the risk of ischemic stroke if they become dislodged and migrate to the brain, forming an obstruction that cuts off the flow of blood and oxygen.

More research is needed to ascertain exactly how HIV increases the risk of plaques, but in the discussion session Chow noted a previously published study that reported that monocyte activation is higher in HIV-positive people -- and highest of all in HIV-positive women -- and that this correlated with coronary artery calcification as well.

How to most effectively prevent stroke in people living with HIV -- other than to reduce traditional risk factors and to provide earlier ART -- is the topic of on-going research.

 

3/8/16

References

HM Crane, F Chow, KJ Becker, et al. Design, Implementation, and Findings of Next-Generation Stroke Adjudication in HIV. 2016 Conference on Retroviruses and Opportunistic Infections (CROI 2016). Boston, February 22-25, 2016. Abstract 636.

CI Hatleberg, D Kamara, L Ryom, et al. Differences in Predictors for Ischaemic and Haemorrhagic Strokes in HIV+ Individuals. 2016 Conference on Retroviruses and Opportunistic Infections (CROI 2016). Boston, February 22-25, 2016. Abstract 637.

F Chow, S Regan, SE Looby, et al. Persistently Increased Ischemic Stroke Risk in HIV-Infected Women. 2016 Conference on Retroviruses and Opportunistic Infections (CROI 2016). Boston, February 22-25, 2016. Abstract 638.

J Berenguer, A Alvaro-Meca, A Diaz, et al. Stroke in HIV-Infected Patients in the Combination Antiretroviral Therapy Era. 2016 Conference on Retroviruses and Opportunistic Infections (CROI 2016). Boston, February 22-25, 2016. Abstract 639.

S Janjua, T Staziaki, R Takx, et al. Incidental Carotid Plaque in HIV is Associated With Subsequent Cerebrovascular Events. 2016 Conference on Retroviruses and Opportunistic Infections (CROI 2016). Boston, February 22-25, 2016. Abstract 640.